These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. Ortu P, LaMuraglia GM, Roberts WG, Flotte TJ, Hasan T. Circulation; 1992 Mar; 85(3):1189-96. PubMed ID: 1537115 [Abstract] [Full Text] [Related]
3. Photodynamic therapy inhibition of experimental intimal hyperplasia: acute and chronic effects. LaMuraglia GM, ChandraSekar NR, Flotte TJ, Abbott WM, Michaud N, Hasan T. J Vasc Surg; 1994 Feb; 19(2):321-9; discussion 329-31. PubMed ID: 8114192 [Abstract] [Full Text] [Related]
4. Selective targeting and photodynamic destruction of intimal hyperplasia by scavenger-receptor mediated protein-chlorin e6 conjugates. Nagae T, Louie AY, Aizawa K, Ishimaru S, Wilson SE. J Cardiovasc Surg (Torino); 1998 Dec; 39(6):709-15. PubMed ID: 9972886 [Abstract] [Full Text] [Related]
5. Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis. LaMuraglia GM, Klyachkin ML, Adili F, Abbott WM. J Vasc Surg; 1995 Jun; 21(6):882-90; discussion 889-90. PubMed ID: 7776467 [Abstract] [Full Text] [Related]
7. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. Bachor R, Flotte TJ, Scholz M, Dretler S, Hasan T. J Urol; 1992 May; 147(5):1404-10. PubMed ID: 1569696 [Abstract] [Full Text] [Related]
13. Comparison of two routes of photosensitizer administration for photodynamic therapy of bladder cancer. Bachor R, Hautmann R, Hasan T. Urol Res; 1994 Jun; 22(1):21-3. PubMed ID: 8073537 [Abstract] [Full Text] [Related]
14. Photodynamic therapy with chloroaluminum-sulfonated phthalocyanine. Stern SJ, Thomsen S, Small S, Jacques S. Arch Otolaryngol Head Neck Surg; 1990 Nov; 116(11):1259-66. PubMed ID: 1700721 [Abstract] [Full Text] [Related]
16. Photodynamic laser cyclodestruction with chloroaluminum sulfonated phthalocyanine (CASPc) or Photofrin (PII) vs. Nd:YAG laser cyclodestruction in a pigmented rabbit model. Hill RA, Esterowitz T, Ryan J, Liaw LH, Nelson JS, Yashiro H, Krasieva T, Berns MW. Lasers Surg Med; 1995 Oct; 17(2):166-71. PubMed ID: 8569412 [Abstract] [Full Text] [Related]
17. Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. Chan WS, Marshall JF, Svensen R, Bedwell J, Hart IR. Cancer Res; 1990 Aug 01; 50(15):4533-8. PubMed ID: 2369730 [Abstract] [Full Text] [Related]
18. Photodynamic therapy of spontaneous cancers in felines, canines, and snakes with chloro-aluminum sulfonated phthalocyanine. Roberts WG, Klein MK, Loomis M, Weldy S, Berns MW. J Natl Cancer Inst; 1991 Jan 02; 83(1):18-23. PubMed ID: 1824598 [Abstract] [Full Text] [Related]
19. Retinal and choroidal vessel closure using phthalocyanine photodynamic therapy. Kliman GH, Puliafito CA, Grossman GA, Gregory WA. Lasers Surg Med; 1994 Jan 02; 15(1):11-8. PubMed ID: 7997044 [Abstract] [Full Text] [Related]
20. In vitro photosensitization I. Cellular uptake and subcellular localization of mono-L-aspartyl chlorin e6, chloro-aluminum sulfonated phthalocyanine, and photofrin II. Roberts WG, Berns MW. Lasers Surg Med; 1989 Jan 02; 9(2):90-101. PubMed ID: 2523995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]